Urgent.News

What's breaking now, across thousands of outlets.

Editions

Finance & Markets

BioSyent Releases Financial Results for Q2 and H1 2026

MISSISSAUGA, Ontario, Aug. 20, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its consolidated financial results for the three months (Q2), six months (H1), and trailing twelve months (TTM) ended June 30, 2026. Key highlights include: (CAD) Q2 2026 % Changevs. Q2 2025 H1 2026 % Changevs. […]

We haven't written up this one. Financial Post has the full story — the link below goes straight to it.

Read the original at financialpost.com →

More in Finance & Markets

More from Thursday 20 August →